Venous Thromboembolism Prophylaxis Policy - Royal United ...

More documents

Recommendations

Info

Appendix 4b: Day Surgery Thromboprophylaxis Guideline The following procedures are low risk: • Ophthalmological procedures with local anaesthetic/regional anaesthetic/sedation and not full general anaesthetic • Non-cancer ENT surgery lasting less than 90 minutes with local anaesthetic /regional anaesthetic / sedation and not full general anaesthetic • Non-cancer dental and maxillo-facial surgery lasting less than 90 minutes with local anaesthetic / regional anaesthetic / sedation and not full general anaesthetic Risk assessment to be completed on day surgery drug chart. If VTE risk high: • Start mechanical VTE prophylaxis at admission and continue mechanical thromboprophylaxis until mobility no longer significantly reduced. Use one of: o Anti-embolism stockings (thigh or knee length) o Foot impulse devices o Intermittent pneumatic compression devices (thigh or knee length) Continue mechanical VTE thromboprophylaxis until the patient no longer has significantly reduced mobility • Add pharmacological VTE prophylaxis for patients who have a low risk of major bleeding. Use LMWH (dalteparin). If the patient is expected to have significantly reduced mobility after discharge, continue pharmacological VTE prophylaxis for 5-7 days. Ensure full blood count and renal function checked prior to commencing. Document name: Venous Thromboembolism Prophylaxis Ref.: 795 Issue date: 30 July 2014 Status: Final Author: Josephine Crowe – Consultant Haematologist Page 36 of 57
Patients having day surgery If VTE risk increased Start mechanical VTE prophylaxis at admission 1 Continue until mobility no longer significantly reduced If risk of bleeding is low Add LMWH (dalteparin), or UFH 2. Continue until mobility no longer significantly reduced including after discharge (generally 5-7 days) 1: Choose any of the following: • Anti-embolitic stockings (thigh or knee length) • Foot impulse devices • Intermittent pneumatic compression devices (thigh or knee length) 2 : For patients with renal failure (eGFR
Page 1 and 2: Venous Thromboembolism Prophylaxis
Page 3 and 4: Appendix 2: General Medicine Thromb
Page 5 and 6: 3 Definition of Terms Used AES DH D
Page 7 and 8: Surgical patients on the combined o
Page 9 and 10: 7.2 Pharmacological prophylaxis and
Page 11 and 12: • Untreated inherited bleeding di
Page 13 and 14: Intermittent pneumatic compression
Page 15 and 16: References 1. Scottish Intercollegi
Page 17 and 18: Appendix 1: Guideline for the Preve
Page 19 and 20: Appendix 2: Guideline General Medic
Page 21 and 22: Sequential Compression Devices for
Page 23 and 24: PATIENTS IN PALLIATIVE CARE If pati
Page 25 and 26: Patients with cancer Patients with
Page 27 and 28: Antenatal VTE risk assessment Previ
Page 29 and 30: Ante-natal or postnatal weight 170
Page 31 and 32: • Varicose veins with phlebitis
Page 33 and 34: Appendix 4a: Vascular, Gastrointest
Page 35: Patients undergoing general surgery
Page 39 and 40: • HRT or oestrogen-containing con
Page 41 and 42: Dalteparin Rivaroxaban 10mg po OD T
Page 43 and 44: ELECTIVE HIP REPLACEMENT ELECTIVE K
Page 45 and 46: UKA, TKA, revision TKA • IPC (kne
Page 47 and 48: HIP FRACTURE OTHER ORTHOPAEDIC SURG
Page 49 and 50: Appendix 5b: Trauma and Orthopaedic
Page 51 and 52: Appendix 5c: Trauma and Orthopaedic
Page 53 and 54: Appendix 6: Critical Care Thrombopr
Page 55 and 56: Document Control Information Ratifi
Page 57: Equality Impact: (A) Assessment Scr

Venous Thromboembolism Prophylaxis Policy - Royal United ...

Create successful ePaper yourself

Delete template?

Save as template?